Valuation Shanghai Rendu Biotechnology Co., Ltd.
Stocks
688193
CNE1000059K5
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Shanghai S.E.
2026-09-03
|
5-day change | 1st Jan Change | ||
| 48.20 CNY | -1.51% |
|
+0.46% | -0.35% |
| 08-28 | Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-14 | Shanghai Rendu Biotechnology's share trade to resume from May 15 | RE |
Company Valuation: Shanghai Rendu Biotechnology Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 1,869 | 1,805 | 1,384 | 1,876 |
| Change | - | -3.42% | -23.32% | 35.54% |
| Enterprise Value (EV) 1 | 1,049 | 1,026 | 586.3 | 1,061 |
| Change | - | -2.19% | -42.87% | 80.99% |
| P/E | 76.6x | 215x | -179x | 186x |
| PBR | 1.94x | 1.87x | 1.52x | 2.05x |
| PEG | -1.1x | -3.3x | 1x | -1x |
| Capitalization / Revenue | 6.15x | 11x | 7.8x | 11.6x |
| EV / Revenue | 3.45x | 6.24x | 3.31x | 6.55x |
| EV / EBITDA | 60.2x | -76.4x | -28.1x | 131x |
| EV / EBIT | 209x | -39.1x | -16.8x | -197x |
| EV / FCF | -35.3x | -99x | 31.9x | 69.9x |
| FCF Yield | -2.83% | -1.01% | 3.14% | 1.43% |
| Dividend per Share 2 | 0.125 | 0.2 | 0.2 | 1.15 |
| Rate of return | 0.27% | 0.44% | 0.56% | 2.38% |
| EPS 2 | 0.61 | 0.21 | -0.2 | 0.26 |
| Distribution rate | 20.5% | 95.2% | -100% | 442% |
| Net sales 1 | 303.8 | 164.4 | 177.4 | 161.9 |
| EBITDA 1 | 17.42 | -13.43 | -20.86 | 8.096 |
| EBIT 1 | 5.018 | -26.23 | -34.98 | -5.382 |
| Net income 1 | 23.33 | 8.259 | -7.812 | 10.09 |
| Net Debt 1 | -819.4 | -778.4 | -797.5 | -814.5 |
| Reference price 2 | 46.72 | 45.12 | 35.75 | 48.37 |
| Nbr of stocks (in thousands) | 40,000 | 40,000 | 38,709 | 38,778 |
| Announcement Date | 4/25/23 | 4/29/24 | 4/29/25 | 4/28/26 |
1CNY in Million2CNY
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 278M | |
| -50.14x | 16.36x | -119.47x | -.--% | 21.61B | |
| 18.6x | 2.07x | 8.75x | 1.38% | 10.39B | |
| -86.71x | 12.5x | -119.78x | -.--% | 8.24B | |
| 185.11x | 6.56x | 37.72x | -.--% | 7.16B | |
| 21.41x | 4.25x | 11.74x | - | 6.59B | |
| 21.29x | 7.38x | 16.56x | 2.7% | 5.88B | |
| 22.22x | 3.65x | 11.31x | 1.7% | 4.42B | |
| 17.11x | - | - | 3.58% | 2.75B | |
| Average | 18.61x | 7.54x | -21.88x | 1.34% | 7.48B | |
| Weighted average by Cap. | 1.96x | 9.53x | -46.40x | 0.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 688193 Stock
- Valuation Shanghai Rendu Biotechnology Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
